Study Stopped
Recruitment challenges.
Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes
Single-blinded, Two-arm, Randomized Clinical Trial of Patients With Type 2 Diabetes Mellitus That Will Compare'Usual Care' With an 'Enhanced Care' Model of Chronic Disease Management That is Based in the Practices of Family Physicians Participating in Primary Care Networks (PCN's).
2 other identifiers
interventional
22
1 country
1
Brief Summary
The purpose of the study is to determine the efficacy of a family physician practice-based model of chronic disease management (CDM) based in Primary Care Networks (PCN's) that is integrated with the Capital Health Regional Diabetes Program for care of patients with type 2 Diabetes Mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Feb 2008
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 12, 2008
CompletedFirst Posted
Study publicly available on registry
November 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedMay 19, 2017
April 1, 2016
3 years
May 12, 2008
May 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A higher proportion of patients with type 2 diabetes enrolled in the 'enhanced care' arm compared with the patients enrolled 'usual' care' arm will achieve an absolute reduction in their HbaA1c of 1.0% or greater during the study period.
1 year
Secondary Outcomes (1)
A higher proportion of patients with type 2 diabetes in the 'enhanced care' arm compared with the patients enrolled in 'usual care' arm will achieve a 10% or greater reduction in HbA1c values during the study period.
1 year
Study Arms (2)
Usual Care Group
ACTIVE COMPARATORThe 'usual care' study arm (control) will reflect current patterns of care for patients with thpe 2 diabetes in the Capital Health region
Enhanced Care Group
EXPERIMENTALIn the enhanced care group(intervention arm) the participants will receive a multifactorial intervention with three main components that include: optimized medical management, 2) support for development of enhanced patient self management skills, and 3) organized proactive follow-up by chronic disease management teams to support improvement in care.
Interventions
Provides an integrated, proactive approach to the management of patients with chronic diseases (ie: diabetes and sequelae) Wagner Model- care encompassed in 3 overlapping galaxies: wider community; the health care system; and the provider organization. There are 6 essential elements: community resources and policies; health care organization; patient self-management support; delivery system design; decision support; and clinical information systems.
optimized medical management support for development of enhanced patient self management skills organized proactive follow-up chronic disease management teams
Continue under the care of their family physician and specialists with referral to diabetic assessment and treatment centers at the discretion of the patient and physician. Normal manner of care: could attend diabetic self education classes and consultations regarding management of diabetes. Or, participate in other patient self management program of their choice.
Eligibility Criteria
You may qualify if:
- Patients with type 2 diabetes (2003 classification by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus) receiving any therapy with HbA1c of \> or = 7.0% between the ages of 40 - 75 years.
You may not qualify if:
- Type 1 diabetes
- Pregnancy
- Severe diabetic complications that include end stage renal disease requiring dialysis
- Proliferative retinopathy (growth of new vessels on the retina and posterior surface of the vitreous that requires laser therapy)
- Uncontrolled cardiovascular disease (CVS event within 1 year of enrollment)
- Psychiatric disease or cognitive impairment that would interfere with treatment compliance
- Cancer or terminally ill patients with less than 6 months life expectancy
- Blindness
- Other severe co- morbid diseases
- Participation in another intense multifactorial intervention for the management of type 2 diabetes
- Participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta, Dept of Family Medicicne
Edmonton, Alberta, T6G - 2C8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil Bell, MD,MSc,CCFP,FCFP
Professor, Dept of Family Medicine, University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2008
First Posted
November 11, 2008
Study Start
February 1, 2008
Primary Completion
February 1, 2011
Study Completion
December 1, 2011
Last Updated
May 19, 2017
Record last verified: 2016-04